Can Mirena (levonorgestrel) reduce menstrual migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mirena (Levonorgestrel IUD) for Menstrual Migraine

Yes, Mirena can effectively reduce menstrual migraines by stabilizing hormone levels and often reducing or eliminating menstrual bleeding, which removes the hormonal trigger for these headaches.

Mechanism of Action for Migraine Prevention

  • Mirena releases levonorgestrel locally in the uterus, providing a progestin-only contraceptive option
  • Works by:
    • Stabilizing hormone levels, particularly preventing estrogen withdrawal
    • Often reducing or eliminating menstrual bleeding (amenorrhea in many users)
    • Avoiding the estrogen fluctuations that typically trigger menstrual migraines

Evidence Supporting Mirena for Menstrual Migraine

Progestin-only contraceptives like Mirena are recommended for migraine management because:

  1. Safety profile: Progestin-only methods are considered safe for individuals with migraine, including those with aura, as they don't increase stroke risk 1

  2. Hormone stabilization: Menstrual migraines are triggered by estrogen "withdrawal" during the late luteal and menstrual phases 2

  3. Therapeutic approach: For menstrual migraine, maintaining a stable estrogen environment can benefit estrogen-withdrawal migraine 3

  4. Preferred delivery system: Continuous progestogens, as provided by the levonorgestrel intrauterine system (Mirena), are preferred over cyclical progestogens which can adversely affect migraine 3

Treatment Algorithm for Menstrual Migraine

First-line options:

  1. Acute treatment: NSAIDs (acetylsalicylic acid, ibuprofen, diclofenac) or triptans for breakthrough headaches 4

For inadequate response to acute treatments:

  1. Short-term prevention (for pure menstrual migraine):
    • Long-acting NSAIDs or triptans (frovatriptan preferred) for 5 days starting 2 days before expected menstruation 4, 5

For severe or frequent menstrual migraines:

  1. Hormonal prevention options:
    • Levonorgestrel IUD (Mirena) - preferred continuous progestogen option 3
    • Other progestin-only methods (implant, injections, pills) 1

For those who cannot use hormonal methods:

  1. Standard migraine preventives:
    • Beta-blockers (propranolol 80-160mg daily) 4
    • Amitriptyline (10-100mg at night) 4
    • Topiramate (50-100mg daily) 4, 1

Important Considerations

  • Safety advantage: Mirena is safer than combined hormonal contraceptives for women with migraine with aura, who have a 7-fold increased risk of ischemic stroke with estrogen-containing contraceptives 1

  • Monitoring: Regular follow-up is recommended to assess migraine pattern changes and treatment effectiveness 1

  • Potential limitations: Some women may experience hormonal side effects with Mirena, though these are typically less pronounced than with other hormonal methods due to the localized hormone delivery

  • Caution: If Mirena does not adequately control menstrual bleeding, the hormonal fluctuations may still trigger migraines in some women

When to Consider Alternative Approaches

  • If Mirena is not tolerated or contraindicated
  • If breakthrough migraines persist despite Mirena
  • If other migraine triggers beyond menstruation are significant

For women with pure menstrual migraine who don't respond to Mirena, consider adding perimenstrual preventive treatment with frovatriptan, naproxen, or other recommended options 6, 5.

References

Guideline

Contraception and Migraine Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of menstrual migraine by oestradiol implants.

Journal of neurology, neurosurgery, and psychiatry, 1983

Research

Migraine, menopause and hormone replacement therapy.

Post reproductive health, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.